Search

everythinglearnresearchcommunity

for

Search:↓

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Tph cells are linked to the severity of systemic lupus erythematosus.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Finasteride increases CD8+ T cells in BPH tissues.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Some thymic peptides can increase human hair growth, while others may inhibit it.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Inhibiting PLA2 enzymes may help treat inflammatory skin diseases like psoriasis and dermatitis.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Compounds from Eclipta prostrata L. plant have diabetes and obesity-fighting properties and reduce inflammation.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.